## HOLX: Hologic, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -0.5% below STRENGTH zone (3.0-6.0%); PEG 1.51 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($74.05)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Mammography Machine Market to hit US$ 4.1 billion by 2033, North**
- Source: openPR.com | 20251209T060914 | Bullish | Relevance: 97%
- The global Mammography Machine Market is projected to reach US$ 4.1 billion by 2033, growing from US$ 2.6 billion in 2024 at a CAGR of 5.1%. This growth is fueled by increasing breast cancer cases, technological advancements, and government health initiatives, with North America currently dominating the market share. Key industry developments include new FDA clearances and product launches from major players like GE HealthCare, Siemens Healthineers AG, and Hologic, Inc., emphasizing digital, 3D tomosynthesis, and AI integration.

**2. 2Xideas AG Decreases Position in Hologic, Inc. $HOLX**
- Source: MarketBeat | 20251209T081924 | Neutral | Relevance: 97%
- 2Xideas AG significantly reduced its stake in Hologic, Inc. by 45.2% in the second quarter, selling over 57,000 shares. Despite this, other institutional investors like Invesco Ltd. and Nordea Investment Management AB increased their holdings in the medical equipment provider. Hologic's stock opened at $74.85, has a market cap of $16.68 billion, and has a consensus "Hold" rating from analysts with an average price target of $79.67.

**3. Edge-GPU Breast Tomosynthesis Box Market Intelligence 2025-2029 Featuring Hologic, GE Healthcare Technologies, Fujifilm, Canon Medical Systems, Philips and More - ResearchAndMarkets.com**
- Source: Markets Financial Content | 20251210T104000 | Somewhat-Bullish | Relevance: 93%
-  The Edge-GPU Breast Tomosynthesis Box market is expected to grow from $0.47 billion in 2024 to $0.88 billion by 2029, driven by advancements in edge computing and rising breast cancer incidence. North America leads the market, with Asia-Pacific projected for the fastest growth. Key players are focusing on enhanced image processing and strategic acquisitions to improve diagnostic capabilities.

**4. Edge-GPU Breast Tomosynthesis Box Market Intelligence 2025-2029 Featuring Hologic, GE Healthcare Technologies, Fujifilm, Canon Medical Systems, Philips and More - ResearchAndMarkets.com**
- Source: The AI Journal | 20251210T155302 | Somewhat-Bullish | Relevance: 80%
-  The Edge-GPU Breast Tomosynthesis Box market is expected to grow from $0.47 billion in 2024 to $0.88 billion by 2029, driven by advancements in edge computing and increased breast cancer incidence. North America currently leads the market, but Asia-Pacific is projected to exhibit the fastest growth. Key players are focusing on enhancing image processing technologies and strategic acquisitions to improve diagnostic accuracy and early detection.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.27M) |
| Sells | 25 ($6.63M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-2.2%)
- T. Rowe Price Invest: 9.7% (-10.5%)
- Blackrock Inc.: 8.7% (-2.7%)
- Manufacturers Life I: 4.7% (-5.2%)
- State Street Corpora: 4.5% (-1.2%)

### Key Risks

1. Insider selling cluster: $6.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.51 elevated, pricing in significant growth expectations. Balance sheet: strong liquidity (3.5x). Insider selling cluster ($6.6M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.7B |
| Beta | 0.70 |
| 52W Range | $51.90 - $76.29 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.51 |
| Forward P/E | 15.0 |
| Current P/E | 16.4 |
| YoY Growth | 9.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+1.0% over 5 days). Below STRENGTH zone by 3.5pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.49% (CS: 32) | Neutral |
| RSI_14 | 64.3 | Neutral |
| MACD Histogram | -0.15 | Bearish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 1.029x | Above |
| vs SMA200 | 1.143x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $74.83
- **Stop Loss:** $74.05 (1.0% risk)
- **Target:** $75.61 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1769
- **Position Value:** $132,374.27
- **Portfolio %:** 132.37%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-04 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.10 | $1.13 | +2.7% |
| 2025Q2 | $1.05 | $1.08 | +2.7% |
| 2025Q1 | $1.02 | $1.03 | +1.4% |
| 2024Q4 | $1.02 | $1.03 | +1.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*